Trends in anemia management in US hemodialysis patients 2004–2010

被引：0
作者：
Dana C Miskulin
Jing Zhou
Navdeep Tangri
Karen Bandeen-Roche
Courtney Cook
Patti L Ephraim
Deidra C Crews
Julia J Scialla
Stephen M Sozio
Tariq Shafi
Bernard G Jaar
L Ebony Boulware
机构：
[1] Tufts University School of Medicine,Division of Nephrology
[2] Johns Hopkins School of Medicine,Division of General Internal Medicine
[3] University of Manitoba,Division of Nephrology
[4] Johns Hopkins Bloomberg School of Public Health,Department of Biostatistics
[5] Johns Hopkins Bloomberg School of Public Health,Department of Epidemiology
[6] Welch Center for Prevention,Division of Nephrology
[7] Epidemiology,Department of Medicine
[8] and Clinical Research,undefined
[9] Johns Hopkins Medical Institutions,undefined
[10] Johns Hopkins University School of Medicine,undefined
[11] University of Miami School of Medicine,undefined
[12] Nephrology Center of Maryland,undefined
[13] Tufts Medical Center,undefined
来源：
BMC Nephrology | / 14卷
关键词：
Anemia; Erythropoietin stimulating agents; Hemodialysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 71 条
[1]  
Remuzzi G(2006)Correction of anemia–payoffs and problems N Engl J Med 355 2144-2146
[2]  
Ingelfinger JR(2010)Erythropoiesis-stimulating agents–time for a reevaluation N Engl J Med 362 189-192
[3]  
Unger EF(2006)Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2085-2098
[4]  
Thompson AM(1998)The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 584-590
[5]  
Blank MJ(2006)Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 2071-2084
[6]  
Temple R(2007)Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients’ Response to IV Iron with Elevated Ferritin (DRIVE) Study J Am Soc Nephrol 18 975-984
[7]  
Singh AK(2009)A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2019-2032
[8]  
Szczech L(2009)Computerized decision support for EPO dosing in hemodialysis patients Am J Kidney Dis 54 1081-1088
[9]  
Tang KL(2013)The DOPPS practice monitor for US dialysis care: trends through December 2011 Am J Kidney Dis 61 342-346
[10]  
Barnhart H(undefined)undefined undefined undefined undefined-undefined
12345678